We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04136353
Brief Title: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)

First Submitted : October 17, 2019
First Submitted that Met QC Criteria : October 21, 2019
First Posted : October 23, 2019

Last Update Submitted that Met QC Criteria : February 1, 2023
Last Update Posted : February 3, 2023 (Estimate)